Credit Suisse Downgrades Amgen (AMGN) to Neutral
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $366.05 -0.05%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 29
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 29
Join SI Premium – FREE
Credit Suisse downgraded Amgen (NASDAQ: AMGN) from Outperform to Neutral.
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Shares of Amgen closed at $82.08 yesterday.
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Shares of Amgen closed at $82.08 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Prabhudas Lilladher Downgrades Kirloskar Pneumatic Co Ltd (KKPC:IN) to Accumulate (2)
- Barclays Downgrades NextEnergy Solar Fund (NESF:LN) to Underweight
- Jefferies Downgrades Henry Boot Plc (BOOT:LN) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
